The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Pancreas Cancer-Associated Weight Loss
Open accessAbstract
Unintentional weight loss in patients with pancreatic cancer is highly prevalent and contributes to low therapeutic tolerance, reduced quality of life, and overall mortality. Weight loss in pancreatic cancer can be due to anorexia, malabsorption, and/or cachexia. Proper supportive care can stabilize or reverse weight loss in patients and improve outcomes. We review the literature on supportive care relevant to pancreatic cancer patients, and offer evidence-based recommendations that include expert nutritional assessment, counseling, supportive measures to ensure adequate caloric intake, pancreatic enzyme supplementation, nutritional supplement replacement, orexigenic agents, and exercise. Pancreatic Cancer Action Network-supported initiatives will spearhead the dissemination and adoption of these best supportive care practices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
Schmitz, K. H., Courneya, K. S., Matthews, C., Demark-Wahnefried, W., GALVÃO, D. A., Pinto, B. M., IRWIN, M. L., WOLIN, K. Y., SEGAL, R. J., LUCIA, A., et al. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e0c112 · Cited by 2,781
Nutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
White, J. V., Guenter, P., Jensen, G., Malone, A., Schofield, M., Academy Malnutrition Work Group, A.S.P.E.N. Malnutrition Task Force, & and the A.S.P.E.N. Board of Directors (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112440285 · Cited by 1,284
Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J. F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00986-1 · Cited by 1,222 · cited 1×
“Additionally, current chemotherapy regimens, including gemcitabine/nabpaclitaxel [40], FOLIFIRINOX [41], and nanoliposomal irinotecan/5FU [42], can cause nausea, vomiting, indigestion, Figure 1.”
BackgroundTemel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., & Fearon, K. C. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00558-6 · Cited by 639
Mishra, S. I., Scherer, R. W., Snyder, C., Geigle, P., & Gotay, C. (2014) · Oncology Nursing Forum · doi:10.1188/14.onf.e326-e342 · Cited by 170 · cited 1×
“PA resulted in improved treatment tolerance [134, 135] and is associated with improved PFS and OS [136], suggesting that the benefit of PA is not confined to disease-free survivors.”
Background
Cited by
Bossi, P., Delrio, P., Mascheroni, A., & Zanetti, M. (2021) · Nutrients · doi:10.3390/nu13061980 · Cited by 465
Naumann, P., Eberlein, J., Farnia, B., Liermann, J., Hackert, T., Debus, J., & Combs, S. E. (2019) · Cancers · doi:10.3390/cancers11111655 · Cited by 54
Metadata
- Authors
- Hendifar, A. E., Petzel, M. Q. B., Zimmers, T. A., Denlinger, C. S., Matrisian, L. M., Picozzi, V. J., Rahib, L., & on behalf of the Precision Promise Consortium
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-12-27
- Volume
- 24
- Issue
- 5
- Pages
- 691-701
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2908183275
- Cited by
- 169
- References
- 12
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pancreas Cancer-Associated Weight Loss. https://app.cochat.ai/papers/10.1634/theoncologist.2018-0266
- The paper
- Hendifar, A. E., Petzel, M. Q. B., Zimmers, T. A., Denlinger, C. S., Matrisian, L. M., Picozzi, V. J., Rahib, L., & on behalf of the Precision Promise Consortium. (2019). Pancreas Cancer-Associated Weight Loss. The Oncologist. https://doi.org/10.1634/theoncologist.2018-0266
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.